Additionally, studies have suggested that HMGB1-driven inflammation correlates with disease severity and could serve as a biomarker to distinguish eosinophilic from non-eosinophilic CRS phenotypes. The gene discussed is HMGB1; the disease is congenital rubella syndrome.